Isomorphic Labs Secures $600M to Advance AI Drug Design

Isomorphic Labs, a spinout from DeepMind, has raised $600 million in its first external funding round led by Thrive Capital, with participation from Google Ventures and Alphabet.

Isomorphic Labs, a spinout from DeepMind, has raised $600 million in its first external funding round. The round was led by Thrive Capital, with participation from Google Ventures and Alphabet. This funding aims to accelerate the development of Isomorphic Labs' AI drug design engine and advance its drug candidates to clinical trials by the end of the year.

The company, headquartered in London with an office in Lausanne, Switzerland, is focused on reducing the time required to discover new medicines. It leverages DeepMind's AlphaFold technology to predict protein interactions with other molecules, applying this to a broader range of biological molecules. Isomorphic Labs has partnered with pharmaceutical giants like Eli Lilly and Novartis and is primarily focused on oncology and immunology.

Demis Hassabis, founder and CEO of Isomorphic Labs, stated that the funding will enhance their AI research and development efforts and expand their team. The company has been on a rapid growth trajectory since its inception in 2021, having quadrupled its R&D spending in 2023.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Healthcare & Life Sciences AI

AI Brief (X)

More from: Funding

Clio to Acquire vLex for $1 Billion, Expanding AI Legal Technology

Jun 30

Recognize Closes $1.7 Billion Fund for Digital Services Investments

Jun 30

Chang Robotics Fund Deploys Initial Capital to Boost U.S. Manufacturing

Jun 30

Audos Secures $11.5 Million to Empower AI Entrepreneurs

Jun 30

Gensmo Secures $60M to Revolutionize Fashion E-Commerce with AI

Jun 30

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.